REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA

Clinical trials for REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope when CAR-T fails: experimental drug targets stubborn lymphoma

Disease control Completed

This study tested an experimental drug called glofitamab for patients with aggressive lymphomas whose cancer returned or didn't respond after CAR-T cell therapy. The trial enrolled 67 patients across two groups with different lymphoma types. Researchers aimed to see if this new a…

Matched conditions: REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA

Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA

Get alerted when new REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL CELL LYMPHOMA trials appear

New hope when CAR-T fails: experimental drug targets stubborn lymphoma